Telecom Lead Britain: Telecommunications major BT
has introduced BT for Life Sciences R&D, a first cloud service designed to
enable collaboration within the life sciences industry for increased R&D
productivity.
The BT for Life Sciences R&D platform is supported by
the BT Assure portfolio of security services.
BT has also entered into an alliance with Accelrys, a
scientific enterprise R&D software and services company, to bring
additional features to the platform.
The alliance will enable use of Accelrys scientific
applications in BT for Life Sciences R&D and provide on-demand services for
Accelrys customers.
The new service allows customers to comply with the industry’s
stringent security, regulatory and compliance requirements in a way that is
suitable for many regulated applications a company may wish to deploy.
“Now companies can potentially reduce research costs
and accelerate time to market by collaborating with third parties in a secure
and compliant environment, and bring innovative solutions to market faster
through computer simulation and modeling,” said Bas Burger, president of Global
Commerce for BT Global Services.
BT for Life Sciences R&D is being developed to become
a secure and segregated platform for scientists in pharmaceutical, biotech,
devices & diagnostics companies as well as in academia and government.
The R&D will allow them to construct and orchestrate
in silico workflows and data pipelines to identify new pharmaceutical targets
and drug candidates.
Furthermore, the ecosystem will allow the group to
securely upload documents, share results and communicate via IM, voice, video
or chat to analyze results in an environment that segments data and uses
qualified hardware components and workflows specific to the pharmaceutical
industry.
Aiming enterprises, BT adds new capabilities to BT Assure
security portfolio
Recently, BT added new capabilities to its BT Assure
security portfolio. The innovation is designed to assist organizations address
security issues.
